Delegation of duties.

(1) A registered nurse may delegate a task to a certified nursing assistant certified under part II of this chapter or a home health aide or a home health aide for medically fragile children as defined in s. 400.462 if the registered nurse determines that the certified nursing assistant or the home health aide is competent to perform the task, the task is delegable under federal law, and the task meets all of the following criteria:

(a) Is within the nurse’s scope of practice.

(b) Frequently recurs in the routine care of a patient or group of patients.

(c) Is performed according to an established sequence of steps.

(d) Involves little or no modification from one patient to another.

(e) May be performed with a predictable outcome.

(f) Does not inherently involve ongoing assessment, interpretation, or clinical judgment.

(g) Does not endanger a patient’s life or well-being.

(2)(a) A registered nurse may delegate to a certified nursing assistant the administration of oral, transdermal, ophthalmic, otic, inhaled, or topical prescription medication to a resident of a nursing home facility as defined in s. 400.021 if the certified nursing assistant meets the requirements of s. 400.211(5) and s. 464.2035.

(b) A registered nurse may delegate to a certified nursing assistant, a home health aide, or a home health aide for medically fragile children the administration of oral, transdermal, ophthalmic, otic, rectal, inhaled, enteral, or topical prescription medications to a patient of a home health agency licensed under part III of chapter 400 or to a patient in a local county detention facility as defined in s. 951.23(1) if the certified nursing assistant or home health aide meets the requirements of s. 464.2035 or s. 400.489, respectively.

(c) A registered nurse may not delegate the administration of any controlled substance listed in Schedule II, Schedule III, or Schedule IV of s. 893.03 or 21 U.S.C. s. 812, except for the administration of an insulin syringe that is prefilled with the proper dosage by a pharmacist or an insulin pen that is prefilled by the manufacturer.

(3) The board, in consultation with the Agency for Health Care Administration, shall adopt rules to implement this section.